Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
17 oct. 2022 08h00 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Logo.jpg
ProPhase Labs to Present at the Q4 Investor Summit Conference
10 nov. 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Logo.jpg
ProPhase Labs to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
07 sept. 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 07, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Logo.jpg
ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
12 juil. 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announced that Chief...
Logo.jpg
ProPhase Labs Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
01 juil. 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, July 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, announced today that it has...
Logo.jpg
ProPhase Labs Added to the Russell Microcap Index
28 juin 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announces that it has...
Logo.jpg
ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
13 mai 2021 16h05 HE | ProPhase Labs, Inc.
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
Logo.jpg
ProPhase Labs to Provide COVID-19 Testing for Oyster Bay Township in New York
22 avr. 2021 08h30 HE | ProPhase Labs, Inc.
ProPhase Labs Will Offer State-Of-The-Art Testing to Aid Oyster Bay Community in Reopening GARDEN CITY, NY, April 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified...
Logo.jpg
ProPhase Labs to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time
15 avr. 2021 08h01 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, April 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Thursday, May 13, 2021 at...
Logo.jpg
ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results
31 mars 2021 09h05 HE | ProPhase Labs, Inc.
Recent Acquisition of Digital COVID-19 Vaccination and Testing “Passport” Transforms the Company’s Portal Into a Universal Digital Certificate Solution and Uniquely Positions Company for Re-Opening...